Skip to main content
. 2021 Nov 22;12:780937. doi: 10.3389/fphar.2021.780937

FIGURE 4.

FIGURE 4

Predicted mean plasma concentration–time curves of apatinib with or without co-administration of CYP 3A4 inhibitors, erythromycin (A), and verapamil (B).